Nurix Therapeutics, Inc. NRIX Unrealized gain, short-term
Unrealized gain, short-term at other companies
Other financials
Where this comes from
Reported directly by Nurix Therapeutics, Inc. in its filing.
Tagged under the XBRL concept nrix:DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTaxCurrent.
The official record: Nurix Therapeutics, Inc.’s 10-Q, filed April 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nurix Therapeutics, Inc.'s unrealized gain, short-term.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nurix Therapeutics, Inc.'s unrealized gain, short-term?
- Nurix Therapeutics, Inc. (NRIX) reported unrealized gain, short-term of $88K in Q4 2025.
- What does unrealized gain, short-term mean?
- This reflects the total accumulated gross unrealized gains on short-term debt securities held as available-for-sale. It highlights the market-to-market performance of the company's near-term liquidity reserves. Investors use this to gauge the efficiency of the company's short-term treasury management.